References
- Dale I, Fagcrhol M K, Naesgaard I. Purification and partial characterization of a highly immunogenic human leukocyte protein, the LI antigen. Eur J Biochem 1983; 134: 1–6
- Dale I, Brandtzaeg P, Fagerhol M K, Scott H. Distribution of a new myelomonocytic antigen (LI) in human peripheral blood leukocytes. Am J Clin Path 1985; 84: 24–34
- Brandtzaeg P, Dale I, Fagerhol M K. Distribution of a formalin-resistant myelomonocytic antigen (LI) in human tissues. I. Comparison with other leukocyte markers by paired immunofluorescence and immunoenzyme staining. Am J Clin Path 1987; 87: 681–99
- Andersson K B, Sletten K, Berntzen H B, Dale I, Brandtzaeg P, Jellum E, Fagerhol M K. The leucocyte LI protein: identity with the cystic fibrosis antigen and the calcium-binding MRP-8 and MRP-14 macrophage components. Scand J Immunol 1988; 28: 241–5
- Brandtzaeg P, Dale I, Fagerhol M K. Distribution of a formalin-resistant myelomonocytic antigen (LI) in human tissues. II. Normal and aberrant occurrence in various epithelia. Am J Clin Path 1987; 87: 700–7
- Gabrielsen T-Ö, Dale I, Brandtzaeg P, Hoel P S, Fagerhol M K, EegLarsen T, Thune P O. Epidermal and dermal distribution of a myelomonocytic antigen (LI) shared by epithelial cells in various inflammatory skin diseases. J Am Acad Dermatol 1986; 15: 173–9
- Dale I, Brandtzaeg P. Expression of the epithelial LI antigen as an immunohistochemical marker of squamous cell carcinoma of the lung. Histopath 1989; 14: 493–502
- Dale I, Fagerhol M K, Frigård M. Quantitation of a highly immunogenic leukocyte antigen (LI) by radioimmunoassay: methodological evaluation. J Immunol Meth 1983; 65: 245–55
- Fagerhol M K, Dale I, Andersson T. A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells. Bull Europ Physiopath Resp 1980; 16: 273–81, suppl.
- Stockley R A, Dale I, Hill S L, Fagerhol M K. Relationship of neutrophil cytoplasmic protein (LI) to acute and chronic lung disease. Scand J Clin Lab Invest 1984; 44: 629–34
- Sander J, Fagerhol M K, Bakken J S, Dale I. Plasma levels of the leucocyte LI protein in febrile conditions: relation to aetiology, number of leukocytes in blood, blood sedimentation reaction and C-reactive protein. Scand J Clin Lab Invest 1984; 44: 357–62
- Dorin J R, Novak M, Hill R E, Brock D JH, Secher D S, Van Heyningen V. A clue to the basic defect in cystic fibrosis from cloning the CD antigen gene. Nature 1987; 326: 614–7
- Berntzen H B, Munthe E, Fagerhol M K. The major leukocyte protein LI as an indicator of inflammatory joint disease. Scand J Rheumatol 1988; 251–6, (Suppl. 76)
- Kolstø, Otnaess A-B, Meberg A, Sande H A. Plasma lactoferrin measured by an enzyme-linked immunosorbent assay (ELISA). Measurements on adult and infant plasma. Scand J Haematol 1983; 31: 235–40
- Gullberg R. Influence of plasma preparation technique on the amount of recovered B12-binding proteins. Clin Chim Acta 1971; 33: 173–7
- Babior B M, Cohen H J. Measurement of neutrophil function: phagocytosis, degranulation, the respiratory burst and bacterial killing. Methods in Haematology. Leukocyte Function, M J Cline. Churchill Livingstone, London 1981; 3: 1–38
- Bennett R M, Mohla C. A solid-phase radioimmunoassay for the measurement of lactoferrin in human plasma: variations with age, sex and disease. J Lab Clin Med 1976; 88: 156–66